Schedule 13D ownership disclosure
SOL GEL TECHNOLOGIES
Ordinary Shares, par value NIS 0.1 per share · CUSIP: M8694L103
Event date: 2025-04-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Moshe ArkinReported CIK 0001321178
Shares: 18,449,907 · Class: 61.79%
- M. Arkin Dermatology Ltd.
Shares: 18,068,564 · Class: 60.52%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-25-001535
- Form type
- SCHEDULE 13D/A
- Filer
- Arkin Moshe
- CIK
- CIK 1321178
- Filed
- Apr 30, 2025
- Reporting period
- Apr 28, 2025
- Description
- Schedule 13D beneficial ownership